Jonathan Balfour, Panaxium - Precision Bioelectronic Devices | LSI Europe '22

The company's technology aims to make "untreatable" debilitating neurological conditions treatable via the use of precision bioelectronic devices that target specific cellular behaviors at the microscale.
Speakers
Jonathan Balfour
Jonathan Balfour
CFO/COO, Panaxium